|
MBNL1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.837800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.688600E-01 |
| Normal-vs-Stage2 |
3.342600E-01 |
| Normal-vs-Stage3 |
5.944200E-01 |
| Normal-vs-Stage4 |
7.281200E-01 |
| Stage1-vs-Stage2 |
1.469620E-01 |
| Stage1-vs-Stage3 |
3.054200E-01 |
| Stage1-vs-Stage4 |
4.173000E-01 |
| Stage2-vs-Stage3 |
5.916600E-01 |
| Stage2-vs-Stage4 |
8.539200E-01 |
| Stage3-vs-Stage4 |
8.961600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.738600E-01 |
| Normal-vs-AfricanAmerican |
3.690800E-01 |
| Normal-vs-Asian |
5.827200E-01 |
| Caucasian-vs-AfricanAmerican |
1.550040E-01 |
| Caucasian-vs-Asian |
5.336800E-01 |
| AfricanAmerican-vs-Asian |
7.034200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.018400E-01 |
| Normal-vs-Female |
1.955360E-01 |
| Male-vs-Female |
7.989900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.410600E-01 |
| Normal-vs-Extreme_Weight |
4.379600E-01 |
| Normal-vs-Obese |
6.777400E-01 |
| Normal-vs-Extreme_Obese |
5.866800E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.618800E-01 |
| Normal_Weight-vs-Obese |
5.352800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.226000E-01 |
| Extreme_Weight-vs-Obese |
2.793200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.544400E-01 |
| Obese-vs-Extreme_Obese |
4.841600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.703560E-01 |
| Normal-vs-Age(41-60Yrs) |
1.654820E-01 |
| Normal-vs-Age(61-80Yrs) |
7.781700E-02 |
| Normal-vs-Age(81-100Yrs) |
7.464800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.237600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.181550E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.936400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.564870E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.503600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.621000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.381800E-01 |
| Normal-VS-Type2 PRCC |
6.908000E-01 |
| Normal-VS-KIRP CIMP |
2.329600E-01 |
| Normal-VS-Unclassified PRCC |
1.571980E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.856400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.826500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.234830E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.698610E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.595700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.303200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.181800E-01 |
| Normal-vs-N1 |
3.932200E-01 |
| Normal-vs-N2 |
6.545000E-01 |
| N0-vs-N1 |
3.021000E-01 |
| N0-vs-N2 |
6.039800E-01 |
| N1-vs-N2 |
7.624400E-01 |
|
|
